BM-18 PROLONGED RESPONSE WITH BEVACIZUMAB + NAVELBINE AS THIRD LINE OF TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASES: A CASE REPORT

Approximately 5% of breast cancer (BC) will develop leptomeningeal metastases (LM) during the course of the disease. The median overall survival remains limited to several months despite aggressive treatment. We report the case of a patient with a prolonged response to bevacizumab (BEV) and vinorelb...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Le Rhun, Emilie, Taillibert, Sophie, Zairi, Fahed, Boulanger, Thomas, Farre, Isabelle, Deligny, Nathalie, Bachelot, Thomas, Bonneterre, Jacques
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217918/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou240.18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados